Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574 ·Status: COMPLETED

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

NCT02090530 ·Status: RECRUITING

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

NCT06851975 ·Status: RECRUITING ·Phase: NA

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

NCT00003329 ·Status: COMPLETED

Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes

NCT02355587 ·Status: TERMINATED

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

NCT00806650 ·Status: COMPLETED

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 ·Status: RECRUITING

Neuroblastoma Precision Trial

NCT02868268 ·Status: ACTIVE_NOT_RECRUITING

Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA

NCT00588289 ·Status: COMPLETED

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444 ·Status: RECRUITING

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

NCT06630429 ·Status: ACTIVE_NOT_RECRUITING

Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors

NCT05082701 ·Status: TERMINATED

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

NCT05758948 ·Status: UNKNOWN

Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer

NCT03885908 ·Status: TERMINATED ·Phase: NA

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

NCT03819569 ·Status: COMPLETED ·Phase: NA

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

NCT02215928 ·Status: RECRUITING

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

NCT02566421 ·Status: TERMINATED ·Phase: NA

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

NCT06630273 ·Status: NOT_YET_RECRUITING

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

NCT03073473 ·Status: TERMINATED

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT04028479 ·Status: COMPLETED

Biomolecular Analysis for Predicting Response to Regorafenib

NCT05759195 ·Status: COMPLETED ·Phase: NA

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

NCT06635954 ·Status: RECRUITING

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

NCT06689956 ·Status: RECRUITING

Multicenter Database of Patients With Germ Cell Tumor

NCT02863003 ·Status: COMPLETED

Galleri® in the Medicare Population.

NCT05673018 ·Status: RECRUITING ·Phase: NA